CJC-1295 with DAC 2mg

£20.90

CJC-1295 with DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH 1–29) chemically modified with a Drug Affinity Complex (DAC) to enable extended persistence in experimental systems.

  • OP Labs formerly Oxford Peptides
  • Batch tested Purity: ≥ 99% (HPLC) (HPLC / SEC, typical)
  • CAS Number: 446262-90-4
  • Molecular Formula: C165H269N47O46
  • Amino Acid Sequence: Y-[D-Ala]-DAIFTQSYRKVLAQLSARKLLQDILSR-K(DAC)-NH2 (Mod GRF 1-29 backbone + C-terminal Lys with DAC / maleimidopropionyl; D-Ala at position 2; amide)
  • Molecular Weight: 3647.2

In stock

Add to Cart
OP Labs CJC-1295 with DAC 2mg GHRH analogue research peptide lyophilized powder in glass vial
CJC-1295 with DAC 2mg
£20.90

Free shipping on orders over £20

  • Royal Mail Tracked24
  • Order before 16.00 for same day dispatch
  • Dedicated customer support
  • Guaranteed safe checkout

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

  • OP Labs formerly Oxford Peptides
  • Batch HPLC tested at ≥ 99% purity
  • Storage: –20 °C long term; 2–8 °C short term
  • Sold for research purposes only

CJC-1295 with DAC

Synonyms / Designations: CJC-1295-DAC, DAC:GRF
CAS Number: 446262-90-4
Molecular Formula: C165H269N47O46
Molecular Weight: 3647.2 g/mol
Peptide Classification: Synthetic growth hormone–releasing hormone (GHRH 1–29) analogue conjugated with Drug Affinity Complex (DAC)
Purity: ≥ 99% (HPLC, typical)
Appearance: White to off-white lyophilised powder
Pack Size: 2 mg (total)
Storage: Desiccated, protected from light, stored at –20 °C
Solubility: Soluble in sterile water and buffered aqueous solutions

Description & Mechanism

CJC-1295 with DAC is a synthetic analogue of growth hormone–releasing hormone (GHRH 1–29) that has been chemically modified through conjugation with a Drug Affinity Complex (DAC). The DAC moiety consists of a reactive linker designed to form a covalent association with circulating serum albumin, resulting in prolonged systemic persistence of the peptide in experimental systems. This bioconjugation alters pharmacokinetic behaviour while preserving the core peptide sequence responsible for receptor interaction.

In biochemical and cellular research models, CJC-1295 with DAC interacts with the GHRH receptor expressed on pituitary-derived cells, initiating intracellular signalling cascades associated with growth hormone secretion. Preclinical research studies have examined receptor activation dynamics, signalling duration, and downstream endocrine pathway engagement under extended exposure conditions. Observed molecular and physiological responses are dependent on experimental design, exposure protocol, and model system, and are used to investigate prolonged GHRH receptor signalling rather than defined biological or physiological outcomes.

Applications in Research

  • As a molecular probe to study GHRH receptor binding and activation dynamics.
  • Investigation of growth hormone axis signalling and endocrine feedback mechanisms.
  • In cellular assays examining downstream transcriptional and signalling responses.
  • In preclinical research models assessing extended-duration peptide–receptor interaction resulting from albumin binding

Specifications Summary

ParameterTypical Value / Range
Purity (HPLC)≥ 99%
AppearanceWhite to off-white lyophilised powder
Molecular Weight~3,647.2 g/mol
Peptide TypeSynthetic GHRH analogue with DAC
SolubilityWater, buffered aqueous solutions
Storage–20 °C, desiccated, dark
Pack Size2 mg

Precautions & Notes

  • Experimental behaviour of CJC-1295 with DAC is influenced by albumin binding and concentration.
  • Buffer composition, pH, and ionic strength may affect peptide stability and assay performance.
  • Intended strictly for laboratory research use; not for human or veterinary application.

Keywords: CJC-1295 with DAC, DAC:GRF, GHRH Analogue